Brain Targeting of Antidepressant and Anxiolytic Drugs

Depression and anxiety are high incidence and debilitating psychiatric disorders, usually treated by antidepressant or anxiolytic drug administration, respectively. Nevertheless, this treatment is usually administered orally, but the low permeability of the blood–brain barrier, which serves many fun...

Full description

Bibliographic Details
Published in:	Engineering Proceedings
Main Authors:	Jéssica Antunes, Ana Cláudia Paiva-Santos, Francisco Veiga, Patrícia C. Pires
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	anxiety brain targeting depression drug functionalization intranasal nanosystems
Online Access:	https://www.mdpi.com/2673-4591/31/1/50

Similar Items

Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
by: Jéssica L. Antunes, et al.
Published: (2023-03-01)

The Importance of Nanosystems in Antipsychotic Drugs Brain Targeting
by: Maria Ferreira, et al.
Published: (2022-12-01)

Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
by: Margarida Alberto, et al.
Published: (2022-12-01)

Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs
by: Patrícia C. Pires, et al.
Published: (2022-03-01)

Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
by: Patrícia C. Pires, et al.
Published: (2023-10-01)

Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
by: Maria Daniela Ferreira, et al.
Published: (2023-02-01)

Intranasal Nanoparticles for the Treatment of Depression and Anxiety Disorders
by: Margarida Alberto, et al.
Published: (2022-12-01)

Anti-Inflammatory Drug Repurposing for Intranasal Delivery: Ketoprofen Nanoemulgel Development for the Treatment of Glioma
by: Patrícia C. Pires, et al.
Published: (2023-10-01)

Recent Progress and Challenges Regarding Magnetite-Based Nanoparticles for Targeted Drug Delivery
by: Joanna Kurczewska, et al.
Published: (2024-01-01)

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
by: Zhiyu Jin, et al.
Published: (2022-09-01)

Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route
by: Ahmad Ainurofiq, et al.
Published: (2023-05-01)

Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
by: Patrícia C. Pires, et al.
Published: (2022-12-01)

Manipulation of Lipid Nanocapsules as an Efficient Intranasal Platform for Brain Deposition of Clozapine as an Antipsychotic Drug
by: Ahmed A. Katamesh, et al.
Published: (2024-11-01)

Improving Skin Cancer Treatment by Dual Drug Co-Encapsulation into Liposomal Systems—An Integrated Approach towards Anticancer Synergism and Targeted Delivery
by: Margarida Corte-Real, et al.
Published: (2024-09-01)

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model
by: Mohammed H. Elkomy, et al.
Published: (2023-08-01)

Intranasal delivery of paeoniflorin nanocrystals for brain targeting
by: Chaoyin Wu, et al.
Published: (2020-05-01)

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies
by: Mohammed H. Elkomy, et al.
Published: (2023-06-01)

Brain Glucose Hypometabolism and Brain Iron Accumulation as Therapeutic Targets for Alzheimer’s Disease and Other CNS Disorders
by: Indira Y. Rao, et al.
Published: (2025-02-01)

Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment
by: Randa Mohammed Zaki, et al.
Published: (2022-08-01)

Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery
by: Gui-Feng Tong, et al.
Published: (2017-09-01)

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers
by: Hadel A. Abo El-Enin, et al.
Published: (2023-06-01)

Targeted Strategies Against Coronavirus Using Nanotechnology
by: Mohsen Mohammadgholi, et al.
Published: (2023-12-01)

Tunable Intranasal Polymersome Nanocarriers Triggered Olanzapine Brain Delivery and Improved In Vivo Antipsychotic Activity
by: Ahmed A. Katamesh, et al.
Published: (2025-06-01)

Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats
by: Deborah Dhuyvetter, et al.
Published: (2020-01-01)

Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
by: N. N. Porfiryeva, et al.
Published: (2021-11-01)

Antidepressant and Anxiolytic Effects of Fermented Huauzontle, a Prehispanic Mexican Pseudocereal
by: Lourdes Santiago-López, et al.
Published: (2022-12-01)

Emerging Targeted Delivery Strategies of Nanosystems for Ischemic Stroke Treatment
by: Ren JX, et al.
Published: (2025-06-01)

Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider
by: Xin Shen, et al.
Published: (2023-11-01)

From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery
by: Lijuan Xie, et al.
Published: (2025-01-01)

Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
by: Luciano A. Stecanella, et al.
Published: (2021-10-01)

Formulation and Characterization of Intranasal Drug Delivery of Frovatriptan-Loaded Binary Ethosomes Gel for Brain Targeting
by: Hamzah ML, et al.
Published: (2024-01-01)

Intranasal Mucoadhesive In Situ Gel of Glibenclamide-Loaded Bilosomes for Enhanced Therapeutic Drug Delivery to the Brain
by: Meenakshi Tripathi, et al.
Published: (2025-02-01)

Engineered multifunctional carbon nanotube-doxorubicin conjugates for pH-triggered drug release
by: Lamya Alotaibi, et al.
Published: (2025-01-01)

Atranorin, a Secondary Metabolite of Lichens, Exhibited Anxiolytic/Antidepressant Activity in Wistar Rats
by: Nicol Urbanska, et al.
Published: (2022-11-01)

Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
by: Sayali Dighe, et al.
Published: (2023-12-01)

pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy
by: Joanna Pilch, et al.
Published: (2023-01-01)

Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug
by: Mohammed Ghazwani, et al.
Published: (2023-06-01)

Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases
by: Siavash Iravani, et al.
Published: (2022-09-01)

Recovery of Naringin-Rich Flavonoid Extracts from Agroresidues with Anxiolytic- and Antidepressant-like Effects in Mice
by: Liliana Hernández-Vázquez, et al.
Published: (2022-12-01)

The anxiolytic and antidepressant effect of Stachys Lavandulifolia in the experimental pentylenetetrazole-induced rat model of acute seizure
by: Vahid Azizi, et al.
Published: (2024-01-01)